InvestSMART

ORDINARY FULLY PAID (ASX: OPT) - Announcements

DELISTED - Current share price for OPT : $0.013

ASX company news and announcements for ORDINARY FULLY PAID (OPT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ORDINARY FULLY PAID (OPT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ORDINARY FULLY PAID (OPT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ORDINARY FULLY PAID (OPT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 3B 30 Jun 2017 8:28AM $0.750 $0.013 fallen by 98.27%
- Change of Director's Interest Notice - GK 9 May 2017 8:26AM $0.935 $0.013 fallen by 98.61%
- Change of Director's Interest Notice - MB 9 May 2017 8:26AM $0.935 $0.013 fallen by 98.61%
- Appendix 3B 3 May 2017 9:45AM $0.920 $0.013 fallen by 98.59%
- Opthea Completes A$45 Million Capital Raising 28 Apr 2017 8:33AM $0.905 $0.013 fallen by 98.56%
- Change of Director's Interest Notice - MS 27 Apr 2017 8:55AM $0.920 $0.013 fallen by 98.59%
- Ceasing to be a substantial holder 21 Apr 2017 7:16PM $0.930 $0.013 fallen by 98.60%
- Change in substantial holding 18 Apr 2017 10:19AM $1.005 $0.013 fallen by 98.71%
- Placement Cleansing Statement 12 Apr 2017 9:07AM $1.045 $0.013 fallen by 98.76%
- Appendix 3B 12 Apr 2017 9:04AM $1.045 $0.013 fallen by 98.76%
- Opthea Entitlement Offer Notice to Ineligible Shareholders 10 Apr 2017 9:00AM $1.175 $0.013 fallen by 98.89%
- Opthea Retail Entitlement Offer Booklet 10 Apr 2017 8:31AM $1.175 $0.013 fallen by 98.89%
- ASX Notice - Accelerated Non-Renounceable Entitlement Offer 5 Apr 2017 3:41PM $1.045 $0.013 fallen by 98.76%
- Opthea Successfully Completes Institutional Capital Raising 5 Apr 2017 8:59AM $0.810 $0.013 fallen by 98.40%
- Entitlement Offer Cleansing Statement 3 Apr 2017 10:00AM $0.810 $0.013 fallen by 98.40%
- Appendix 3B 3 Apr 2017 9:55AM $0.810 $0.013 fallen by 98.40%
- Opthea A$45M Equity Raising Launch Presentation 3 Apr 2017 9:33AM $0.810 $0.013 fallen by 98.40%
- Opthea Launches A$45M Financing for Clinical Development 3 Apr 2017 9:28AM $0.810 $0.013 fallen by 98.40%
- Opthea Phase 1/2A wet AMD Trial Update Presentation 3 Apr 2017 9:24AM $0.810 $0.013 fallen by 98.40%
- Opthea Reports Positive Phase 1/2A Clinical Results 3 Apr 2017 9:23AM $0.810 $0.013 fallen by 98.40%
- Trading Halt 3 Apr 2017 9:19AM $0.810 $0.013 fallen by 98.40%
- Opthea to Host Update on OPT-302 Phase 1/2A wAMD Trial 31 Mar 2017 6:06PM $0.810 $0.013 fallen by 98.40%
- Trading Halt 30 Mar 2017 9:53AM $0.810 $0.013 fallen by 98.40%
- Opthea Receives EU Regulatory Feedback for OPT-302 Program 20 Mar 2017 8:28AM $0.950 $0.013 fallen by 98.63%
- Ceasing to be a substantial holder 13 Mar 2017 3:37PM $0.930 $0.013 fallen by 98.60%

676 - 700 of 733 results

Page 28 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.